EVA Air Cargo - Delivering Joy

C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

09

Aug 2022

Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology

Pfizer Inc and Global Blood Therapeutics Inc announced the companies have entered into a definitive agreement under which Pfizer will acquire GBT a biopharmaceutical company dedicated to the discovery development and delivery of lifechanging treatments that provide hope to underserved patient commun...

09

Aug 2022

Thermo Fisher Scientific Launches Enhanced Applied Biosystems HIV-1 Genotyping Kit

Thermo Fisher Scientific the world leader in serving science today announced the launch of its Applied Biosystems HIV Genotyping Kit with Integrase a research use only assay that examines positive samples of human immunodeficiency virus HIV to identify genetic variants that resist common antiretrovi...

05

Aug 2022

Sanofi and Innovent Biologics enter strategic collaboration to accelerate development of oncology medicines and expand presence in China

Sanofi and Innovent Biologics announced a collaboration to bring innovative medicines to patients in China with difficulttotreat cancers Innovent is a leading biopharmaceutical company with strong clinical development capabilities and a broad commercial footprint in China Both companies are committe...

05

Aug 2022

Gilead Sciences to Acquire MiroBio

Gilead Sciences Inc and MiroBio a privatelyheld UKbased biotechnology company focused on restoring immune balance with agonists targeting immune inhibitory receptors today announced that the companies have entered into a definitive agreement pursuant to which Gilead will acquire MiroBio for approxim...

04

Aug 2022

FDA Approves JUVÉDERM® VOLUX™ XC for Improvement of Jawline Definition

Allergan Aesthetics an AbbVie company announced the US FDA approval of JUVDERM VOLUX XC for the improvement of jawline definition in adults over the age of with moderate to severe loss of jawline definition The approval of JUVDERM VOLUX XC represents the largest leap in innovation for our US HA por...

04

Aug 2022

Radiopharm Enters into Strategic Collaboration with Lantheus and Assumes PD-L1 Licensing Agreement From Nanomab

Radiopharm Theranostics a developer of a worldclass platform of radiopharmaceutical products for both diagnostic and therapeutic uses is pleased to announce that it has entered a collaboration agreement with Lantheus for the mutually beneficial development of NM a nanobody made using genetically eng...

press releasesRead more...

08

Aug 2022

U.S. FDA approves additional indication of darolutamide in combination with docetaxel for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC)

Bayer announced today the US Food and Drug Administration FDA has approved a supplemental New Drug Application sNDA for the oral androgen receptor inhibitor ARi darolutamide in combination with docetaxel for the treatment of patients with metastatic hormonesensitive prostate cancer mHSPC The approva...

08

Aug 2022

Maruho Launched in Japan the Anti-IL-31 Receptor A Humanized Monoclonal Antibody Mitchga for the Treatment of Itching Associated with Atopic Dermatitis

Chugai Pharmaceutical Co Ltd announced that Maruho Co Ltd hereafter Maruho launched the antiIL receptor A humanized monoclonal antibody Mitchga Subcutaneous Injection mg Syringes generic name nemolizumab genetical recombination for the treatment of itching associated with atopic dermatitis only whe...

08

Aug 2022

Sartorius to acquire Albumedix, strengthening its portfolio of innovative advanced therapy solutions

The life science group Sartorius through its French listed subgroup Sartorius Stedim Biotech has agreed to acquire percent of Albumedix Ltd from private investors The Nottingham UKbased company provides bestinclass recombinant albuminbased solutions Recombinant human albumin is an important compone...

08

Aug 2022

BioIVT Acquires Cypex, a Leading Manufacturer of Drug-metabolizing Enzymes

BioIVT a leading provider of biospecimens research models and services for drug and diagnostic development today announced that it has acquired Cypex a renowned manufacturer of recombinant xenobiotic metabolizing enzymes based in Dundee Scotland Cypexs extensive enzyme portfolio covers a wide range...

08

Aug 2022

Mersana Therapeutics Announces Option Agreement with GSK for the Co-Development and Commercialization of XMT-2056, an Immunosynthen ADC Targeting HER2

Mersana Therapeutics Inc a clinicalstage biopharmaceutical company focused on discovering and developing a pipeline of antibodydrug conjugates ADCs targeting cancers in areas of high unmet medical need today announced a global collaboration that provides GSK plc LSENYSE GSK an exclusive option to co...

05

Aug 2022

“Pharmaconex” 9th Edition to Launch Next September

Next September Cairo will witness the launch of the th edition of the Pharmaconex exhibition and conference which is considered to be one of the major events in the field of pharmaceuticals The event will be taking place from the thto the thof September at the Egyptian International Exhibition Cent...

EventsRead more...

22 - 23

Aug 2022

31 - 02

Aug 2022

04 - 06

Sep 2022

Pharmaconex

Egypt International Exhibition Centre

06 - 07

Sep 2022

21 - 22

Sep 2022

Therapeutics and Delivery Conference

SMi Group
Copthorne Tara Hotel

27 - 30

Sep 2022

BioProcess International

Boston Convention and Exhibition Center

27 - 30

Sep 2022

Biotech Week Boston

Boston Convention & Exhibition Center

27 - 30

Sep 2022

Cell & Gene Therapy Manufacturing

Boston Convention & Exhibition Center

TOP ARTICLES

KNOWLEDGE BANK

  • Interviews

    Datwyler Pharma Packaging

    Senior Manager Global Scientific Affairs

    Renaud Janssen PhD is the Senior Manager of Global Scientific Affairs at Datwyler Pharma Packaging He frequently presents on international conferences on subjects related to elastomeric and aluminiumplastic closures for pharmaceutical applications Renaud also serves on several standardisation and pharmacopoeia committees as well as on industry task forces
  • Articles

    Alpha-fetoprotein as a Shuttle for Medicines

    Pregnancy is a natural phenomenon that ensures the survival of the species The suppression of the immune response in pregnancy is robust since the embryo cells have half the fathers proteins that should be recognised by the mothers immune system as foreign Even surrogate motherhood is possible with no genetic relationship to the embryo at all The embryo cell is turning

  • Techno Trends

    British scientists discover major treatment for bladder cancer

    A significant breakthrough in years for treating the advanced bladder cancer Scientists from Queen Mary University of London discovered that an antibody allows immune system to gather and eliminate cancer cells before they could spread A cancer immunotherapy medicine named MPDLA being developed by Roche has been admin

EDITORIAL SECTION

  • EXPERT Talk

    PHARMA LOGISTICS TRENDS

    Pharma logistics is undergoing profound change throughout Asia as the ageing population drives a growing need for new pharma solutions together with s...